oNKo-innate is a discovery-stage biotechnology company dedicated to target identification and pre-clinical immuno-oncology drug development. With our deep understanding of ‘Natural Killer' cells, we aim to be the first to truly therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.